The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome.
about
Safety and efficacy of peramivir for influenza treatmentAvian influenza A H7N9 virus induces severe pneumonia in mice without prior adaptation and responds to a combination of zanamivir and COX-2 inhibitorA Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune ResponseInfluenza A(H7N9) virus acquires resistance-related neuraminidase I222T substitution when infected mallards are exposed to low levels of oseltamivir in water.H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in miceMammalian models for the study of H7 virus pathogenesis and transmission.Human H7N9 and H5N1 influenza viruses differ in induction of cytokines and tissue tropism.The Tie2-agonist Vasculotide rescues mice from influenza virus infectionTranslational research on influenza virus infection using a nonhuman primate model.Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.An investigational antiviral drug, DAS181, effectively inhibits replication of zoonotic influenza A virus subtype H7N9 and protects mice from lethality.Sialic acid-binding protein Sp2CBMTD protects mice against lethal challenge with emerging influenza A (H7N9) virusInfluenza A(H7N9) virus transmission between finches and poultry.Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model.The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome.Vascular Permeability Drives Susceptibility to Influenza Infection in a Murine Model of Sickle Cell Disease.TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice.Anti-influenza effect of the major flavonoids from Salvia plebeia R.Br. via inhibition of influenza H1N1 virus neuraminidase.Aerosol administration increases the efficacy of oseltamivir for the treatment of mice infected with influenza viruses.Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques.Pharmacodynamics, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-κB Inhibiting Anti-influenza Drug.The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses
P2860
Q27027408-F25D7BCC-330E-4299-A598-E3B07A6C10F1Q28543086-B0031314-0F76-425D-827C-8B48DB5E306BQ28553101-FF1A031D-AB47-4958-B9C8-B13E4B64935AQ30203367-472467D3-DFC7-44A1-BF62-23863961582AQ30364306-B5D47F29-F5BB-43F7-9C17-92391F6BEE47Q30364385-E57CEA13-E632-4D86-9270-818E7AF0B0E1Q30366672-9CE89F73-AC82-4A28-AEC7-66A67A334F19Q30375351-C3971A78-775D-443F-A1BD-565F4AC6D6B1Q30383873-2138E9EF-94BD-4859-80D1-26B74EBC80CBQ30392198-7A603F08-D1B6-4EF4-A73B-485AD216B403Q33880235-61712EAB-0DB8-43EE-A2CB-5843294EDB3EQ35076835-A4EBBDA0-DF0C-462B-BA64-1DDE40AFA162Q35229641-0F6067F3-211E-4FC1-B9AB-C9AE45B83D49Q35860081-64038E3D-B35D-4243-9E9E-ACBC5CD882CDQ36290711-A60BCF5C-CB8C-4FBF-AC42-D0ED6A79F07AQ36730084-9F6E0540-6451-4BD0-9C8C-4BF908D2018AQ37679060-F864E258-DCD2-4B94-9806-226D7FF90B61Q37713993-82666D58-6E3A-439A-BF59-9C9F97DD659CQ38683940-E60C6BDE-A8B7-4AF6-9B9B-9A1B9CBE47E8Q38912274-25882B59-7572-4F15-AA5B-620D87D8A149Q41933615-DFF59054-A9B9-47F3-BC66-1295644E67CBQ45859986-4F315972-90A6-4F72-8E55-AD533C252C5AQ59136444-A42ADDE3-3BDE-4C01-A077-B5740E7EE87C
P2860
The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The neuraminidase inhibitor os ...... respiratory distress syndrome.
@en
The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013
@nl
type
label
The neuraminidase inhibitor os ...... respiratory distress syndrome.
@en
The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013
@nl
prefLabel
The neuraminidase inhibitor os ...... respiratory distress syndrome.
@en
The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013
@nl
P2093
P2860
P50
P356
P1476
The neuraminidase inhibitor os ...... respiratory distress syndrome.
@en
P2093
Andrew J Burnham
Bindumadhav M Marathe
Jianling Armstrong
Joseph Malik Sriyal Peiris
Tatiana Baranovich
Yuelong Shu
P2860
P304
P356
10.1093/INFDIS/JIT554
P407
P577
2013-10-16T00:00:00Z